Middle East and Africa Empty Capsules Market Research Report – Segmented By Product, Therapeutic Application, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Updated On: January, 2024
ID: 401
Pages: 133

MEA Empty Capsules Market Size (2023 to 2028)

The size of the Empty Capsules Market in the Middle East & Africa is predicted to be worth USD 249.06 million by 2028 from USD 183.42 million in 2023, growing at a CAGR of 6.31% from 2023 to 2028.

On the specified dose form, empty capsules can be stored with herbs, powders, or medicines. The empty capsule can be found in a variety of colors and flavors. Due to their high absorption rates, they are quite popular.

An increase in strategic cooperation between empty capsule providers and gelatin makers and a rise in the appeal of capsules over other drug delivery forms are driving market expansion. In addition, as the world’s senior population grows, the demand for various therapeutic medications and nutritional supplements to improve health outcomes grows.

Furthermore, ongoing research into the manufacture of high-quality empty capsules with the help of government agencies has accelerated the market’s growth rate. In addition, the surge in the popularity of dietary supplements to promote immunity boosts the market’s growth pace. The growing elderly population, the high demand for empty capsules among pharmaceutical, nutraceutical, and cosmeceutical makers, and the growing customer preference for capsules over tablets contribute to the growth of the Middle East Africa empty capsules market.

The growth of the empty capsules market in the MEA region is predicted to be hampered by a dearth of trained workers in laboratories and the government’s strict laws and regulations requiring only high-quality medicines to be approved. In addition, market growth is projected to be hampered by ethical concerns, price variations in gelatin materials, and tight regulations in the pharmaceutical business. Market demand is also hampered by the availability of rival treatments at lower rates and volatility in raw materials costs. Moreover, in this region, a lack of awareness about how to use these items is slowing the growth of the empty capsules market.

This research report on the MEA Empty Capsules Market has been segmented and sub-segmented into the following categories:

By Product:

  • Gelatin Capsules
  • Non-Gelatin Capsules

The gelatin capsules are the most popular product segment, with a major share of the market. Non-gelatin capsules, on the other hand, are expected to grow at the highest rate, with a significant CAGR, due to the rising demand for vegetable origin capsules.

By Therapeutic Application:

  • Antibiotic And Antibacterial Drugs
  • Vitamins And Dietary Supplements
  • Antacid And Antiflatulent Preparations
  • Antianemic Preparations
  • Anti-Inflammatory Drugs
  • Cardiovascular Therapy Drugs
  • Cough And Cold Preparations
  • Other Therapeutic Application

By End User:

  • Pharmaceutical Industry
  • Nutraceutical Industry
  • Cosmetics Industry
  • Research Laboratories

The pharmaceutical industry is the largest end consumer of empty gelatin capsules, accounting for a significant portion of the market, which is expected to remain stable over the forecast period.

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The Middle East accounts for the largest market share within this region, while Africa is estimated to be the fastest-growing region. In the MEA empty capsule market, the Middle East has the biggest market share, while Africa is expected to grow at a higher rate. Most nutraceuticals and cosmeceuticals, such as cod liver oil capsules and CosmoPod capsules, are taken in capsule form. The advantages above of capsule consumption account for the high demand for empty capsules in the various industries throughout the region.

The existence of several capsule producers in the UAE and Nigeria, as well as expansion in the pharmaceutical and nutraceutical industries, and less rigorous rules in the nutraceutical industry in this region, are all factors to consider, a growing focus on generics, and rising healthcare awareness, are expected to drive capsule adoption in the MEA. In addition, antibiotic usage has improved dramatically in recent years. Antibiotics are being used indefinitely to treat diseases across the MEA due to rising antibiotic usage, whether prescribed or over the counter.


Capsugel, ACG Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc., Capscanada Corporation, Medi-Caps Ltd., Qualicaps, Roxlor, LLC, Snail Pharma Industry Co.Ltd. And Sunil Healthcare Limited are playing a dominant role in the MEA Empty Capsules Market.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample